Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

The fight against Alzheimer's disease just got a powerful new ally: women's brains. For too long, research has largely ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

TORONTO -- Blood tests for Alzheimer's disease biomarkers can be used clinically -- and can replace expensive brain scans and ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

New tests and new treatments are presenting more options for certain patients with Alzheimer's disease. “Today a confluence ...

The prospective cohort study, published in The Journal of Nutrition, found that consuming one or more eggs per week was ...

Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...

The Alzheimer’s Association has issued its first clinical practice guideline on the use of blood tests to help diagnose ...